title: How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?
authors.affiliation: McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, Canada.
authors.forename: Zhi Zhen
authors.initials: ZZ
authors.lastname: Qin
authors.affiliation: McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, Canada.
authors.forename: Madhukar
authors.initials: M
authors.lastname: Pai
authors.affiliation: Global TB Progamme, World Health Organization, Geneva, Switzerland.
authors.forename: Wayne
authors.initials: W
authors.lastname: Van Gemert
authors.affiliation: Stop TB Partnership, Geneva, Switzerland.
authors.forename: Suvanand
authors.initials: S
authors.lastname: Sahu
authors.affiliation: McGill International TB Centre, and Dept of Epidemiology and Biostatistics, McGill University, Montreal, Canada.
authors.forename: Marzieh
authors.initials: M
authors.lastname: Ghiasi
authors.affiliation: Stop TB Partnership, Geneva, Switzerland creswellj@stoptb.who.int.
authors.forename: Jacob
authors.initials: J
authors.lastname: Creswell
mesh_terms: D000465:Algorithms; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis; D006291:Health Policy; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D009696:Nucleic Acids / Q000032:analysis; D000067716:Point-of-Care Testing; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011933:Reagent Kits, Diagnostic; D013019:South Africa; D011795:Surveys and Questionnaires; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology*; D014944:World Health Organization
chemical_list: D009696:Nucleic Acids; D011933:Reagent Kits, Diagnostic